Our Team

Rick Simpson has been in the diagnostics business for 25 years, starting Clarity Diagnostics in 2003, and has grown the business from a single dip urinalysis strip test to over 300 SKU’s. His goal from the beginning was to bring the highest quality products to the market with fair competitive pricing and white-glove customer service. In addition to being the founder and CEO of Clarity Diagnostics, Rick also heads Clarity Lab Solutions (www.claritylabsolutions.com), a molecular based highly complex laboratory in Boca Raton, Florida.

Tom was a founding investor with Clarity Diagnostics in 2003 and is currently a managing partner of the Clarity Companies. Tom acted as an advisor to the company for the first 17 years before coming onto a full-time role in 2020, as a business development and corporate liaison. Tom has spent much of his career running a successful PVC Plastics distribution business as well as being a partner in a Cajun/Barbecue restaurant.

Warren currently serves as a managing director for the Clarity Companies with responsibility for strategic planning, finance, and information technology. Warren has delivered business process re-engineering, and global integrated cash management and analytics solutions to Fortune 100 companies including IBM, EDS, and GM as well as several SMB and start-up businesses alike.

Warren most recently served as CEO at SEAD Software, a managed service provider of advanced analytic solutions on a proprietary platform that provides transparency and access to all corporate information on any Internet connected device. Warren has run both public and private companies, provided strategic planning, raised debt and equity, provided financial and operational restructuring with several successful turnarounds.

Dr. Stephen Shaya, MD, stands out as an innovative leader and entrepreneur in healthcare. Guiding Akkad Holdings as the Founder & Managing Director, he directs investments in worldwide healthcare initiatives, complementing his role as Executive Servant Leader at J&B Medical. Over his 17-year tenure at J&B, Dr. Shaya has pioneered 18 business ventures, spotlighting his relentless pursuit of extending the company’s reach through innovation.

In alliance with the Vatican and the Cura Foundation, Akkad Holdings aims to deliver healthcare to those less privileged. Dr. Shaya’s ethos, articulated in the phrase “People. Purpose. Pay It Forward,” shines through his active participation in boards like the American Diabetes Association, The Henry Ford Health System, and Endeavor Detroit. His numerous accolades include the Global Medical Innovation and Leadership Award, Vatican Pontifical Hero Award, and the recently conferred “AAPI Presidential Healthcare Leadership Award 2023.”

With degrees from Wayne State University School of Medicine and training at North Oakland Medical Center, Dr. Shaya’s career exemplifies his unyielding dedication to innovation, empathy, and excellence in healthcare. His impact on the industry has reimagined how healthcare services are approached, providing renewed hope and patient well-being.

Dr. Chalil is an author of several scientific and research papers in international publications, is the Chairman of the Complex Health Systems Advisory Board, H. Wayne Huizenga College of Business and Entrepreneurship at Nova Southeastern University in Florida and a member of Dr. Kiran C. Patel College of Allopathic Medicine (NSU MD) Executive Leadership Council. A U.S. Navy Medical Corps veteran, he is board certified in healthcare management.

He is also the Chief Medical Officer at Novo Integrated Sciences, Inc, and the Chief Strategy Officer of the American Association of Physicians of Indian Origin (AAPI). He has been awarded a Fellowship by the American College of Healthcare Executives, an international professional society of more than 40,000 healthcare executives who lead hospitals, healthcare systems, and other healthcare organizations. Dr. Chalil is the former Chairman of the Indo-American Press Club (IAPC), the largest ethnic fraternity of Indian American and Indian Canadian media, with a mandate to help shape a world through fair, just, and equitable media for all and future generations. He is an expert in U.S. healthcare policy and a strong advocate for patient-centered care.

Kevin joined Clarity Diagnostics in July 2022 bringing over 20 years of sales experience within the health care industry. He joined Clarity directly from Abbott Diagnostics where he worked within the informatics division managing connectivity sales encompassing the northeastern part of the country. Prior to Abbott, he held various roles within Roche Diagnostics.

Jason is an experienced healthcare executive, having served since 2008 as the Director of Finance for Clarity Diagnostics. He is responsible for the oversight and direction of all finance, accounting, and administrative functions at Clarity Diagnostics. Jason graduated with honors from the University of Michigan.

Kevin has 25 years of experience as an advisor to C-suite management and in entrepreneurial ventures, following 10 years of experience at a firm and in private practice as a CPA. Kevin specializes in advising in the fields of corporate renewal & business transformation, business process improvement, enterprise value transformation, debt restructuring and M&A advisory, and bridging finance/operations to technology for data analytics & business intelligence.

Kevin began working with the Clarity Companies in March of 2020, through a period of rapid growth, and maintains a role of advising management, covering CFO duties, managing accounting and finance, internal & external stakeholder relations, and proprietary technologies that Clarity utilizes for business intelligence.